Literature DB >> 3408959

Infection control revisited: dilemma facing today's bronchoscopists.

P J Hanson1, D J Jeffries, J C Batten, J V Collins.   

Abstract

The emergence of the acquired immune deficiency syndrome has provoked a widespread review of policies for infection control. Incomplete knowledge about the human immunodeficiency virus (HIV), hepatitis B virus, and mycobacteria has until now been compensated for by adopting "overkill" precautions for patients who were thought to harbour these organisms. This policy is no longer tenable, given the difficulty in identifying infected patients. The control of infection in hospitals must instead be based on the routine use of high standards of hygiene that are adequate to contain all pathogens. Attempts by bronchoscopists to formulate such a policy have been frustrated by the lack of a suitable disinfectant and by ignorance of the susceptibility of microorganisms to cleaning and disinfection in a clinical environment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3408959      PMCID: PMC1834244          DOI: 10.1136/bmj.297.6642.185

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  17 in total

1.  Decontamination of fibrescopes--recent developments.

Authors:  J R Babb; C R Bradley
Journal:  J Sterile Serv Manage       Date:  1984-10

2.  Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis.

Authors:  J M Ziza; F Brun-Vezinet; A Venet; C H Rouzioux; J Traversat; B Israel-Biet; F Barre-Sinoussi; J C Chermann; P Godeau
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

3.  Inactivation of hepatitis B virus by intermediate-to-high-level disinfectant chemicals.

Authors:  W W Bond; M S Favero; N J Petersen; J W Ebert
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

4.  Inactivation of lymphadenopathy associated virus by chemical disinfectants.

Authors:  B Spire; F Barré-Sinoussi; L Montagnier; J C Chermann
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

5.  Contamination of flexible fiberoptic bronchoscopes.

Authors:  S A Pappas; D M Schaaff; M B DiCostanzo; F W King; J T Sharp
Journal:  Am Rev Respir Dis       Date:  1983-03

6.  Endoscopic transmission of hepatitis B virus.

Authors:  G G Birnie; E M Quigley; G B Clements; E A Follet; G Watkinson
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

7.  Disinfecting endoscopes: how not to transmit Mycobacterium tuberculosis by bronchoscopy.

Authors:  W D Leers
Journal:  Can Med Assoc J       Date:  1980-08-23       Impact factor: 8.262

8.  In-use testing of four glutaraldehyde disinfectants in the Cidematic washer.

Authors:  R A Bageant; F J Marsik; V A Kellogg; D L Hyler; D H Gröschel
Journal:  Respir Care       Date:  1981-12       Impact factor: 2.258

9.  Mycobacterial cross-contamination of bronchoscopy specimens.

Authors:  D J Dawson; J G Armstrong; Z M Blacklock
Journal:  Am Rev Respir Dis       Date:  1982-12

10.  Transmission of tuberculosis by flexible fiberbronchoscopes.

Authors:  K E Nelson; P A Larson; D E Schraufnagel; J Jackson
Journal:  Am Rev Respir Dis       Date:  1983-01
View more
  2 in total

1.  Costs of infection control in endoscopy units.

Authors:  P J Hanson; S Meah; D Tipler; J V Collins
Journal:  BMJ       Date:  1989-04-01

2.  AIDS and UK respiratory physicians: attitudes to confidentiality, infection control, and management.

Authors:  S Church; S Owen; A A Woodcock
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.